The Spanish National Center for Cardiovascular Research (CNIC) by means of its Research & Technology Transfer Office (TTO) ensures that scientific and technological developments generated by the CNIC are accessible to a wider range of users who can then further develop and exploit the technology into new products, processes, applications, materials or services.

CNIC scientific area is organized into two departments focused on Basic Research and Clinical Research, fully interconnected through six multidisciplinary programs grouped into three research areas:

1 Vascular Pathophysiology
2 Myocardial Pathophysiology
3 Cell Developmental Biology

Our portfolio include biomarkers, genetic and diagnostic tools, animal models and treatments for cardiovascular, inflammatory and infectious diseases, among others. Some examples of our current projects include treatment for pulmonary hypertension, myeloproliferative diseases and trained immunity for prevention of infections. Regarding diagnosis, we are currently working on biomarkers for myocarditis, subclinical atherosclerosis and calcific aortic valve disease.

Research areas of interest (16)

  • Biological Sciences
  • Medicine, Human Health
  • Diagnostics, Diagnosis
  • Heart and blood circulation illnesses
  • Medical Research
  • and 11 more

CNIC (TTO) didn't publish any Technology Call yet

Scientists at the Centro Nacional de Investigaciones Cardiovasculares and Centro de Biología Molecular Severo Ochoa (CBM-CSIC-UAM) have discovered that the nitric oxide (NO) pathway is overactivated in the aortas of mice and patients with Marfan Syndrome and that the activity of this pathway causes […]

Inflammation is an active driver of atherosclerotic plaque development and a risk factor for atherosclerotic events. It is therefore of utmost importance to understand the mechanisms behind these inflammatory processes and to be able to develop new diagnostics and treatment modalities for atheroscle[…]

Novel atherosclerosis biomarkers are in need to improve the strategies for diagnosis and prognosis of cardiovascular disease. CNIC and DKFZ researchers have discovered 18 novel antibodies that show reactivity against the atherosclerotic plaque, which can thus be potentially used for the diagnosis of[…]

Most analysis of gene function in biomedical research relies on the use of Cre-lox technology. Since its introduction in 1994, this technology has revolutionized biomedical science because it allows scientists to eliminate or activate the function of any gene in any cell type in the mouse. Because t[…]

Myelodysplastic/myeloproliferative neoplasms (MPN) are a group of diseases that affect normal blood cell production in the bone marrow. In this case the bone marrow causes an overproduction of one or more blood cell types (red cells, white cells or platelets). Complications arise over time due to th[…]

Pulmonary hypertension (PH), defined as the increase of mean pulmonary blood pressure above normal values, encompasses a series of disorders characterized by the increase of pulmonary vascular resistance and progressive deterioration of the right ventricle. The incidence of pulmonary hypertension in[…]

Inflammation in the myocardium or myocarditis is a disease with heterogeneous aetiology, frequently caused by an infectious pathogen, toxins, drugs or by an autoimmune disorder. Its clinical variability and its nonspecific symptoms make the diagnosis of myocarditis a process that is not always easy.[…]

Trained immunity can be defined as a defacto innate immune memory that induces enhanced inflammatory and antimicrobial properties in innate immune cells. Innate immune cells can be trained to exhibit an enhanced and lasting response to subsequent infections with microbial components. Importantly, th[…]

CNIC (TTO) didn't publish any Paper yet

CNIC (TTO) didn't publish any Event yet

CNIC (TTO) didn't publish any Job yet

CNIC (TTO) didn't publish any New and Article yet

CNIC (TTO) didn't publish any Education Resource yet

You are signed out

Join Innoget to connect with CNIC (TTO) and thousands
of innovation-driven professionals and organizations